The obesity paradox in cancer: clinical insights and perspectives

Eat Weight Disord. 2018 Apr;23(2):185-193. doi: 10.1007/s40519-018-0489-y. Epub 2018 Feb 28.

Abstract

A series of evidence demonstrated that obesity represents an established risk factor for an increase in the incidence of multiple cancer types and for poor cancer survival. Nevertheless, recent studies suggested that, in a series of cancers, patients with a normal body mass index (BMI) have worse outcomes than obese patients. This phenomenon, named 'obesity paradox' or 'reverse epidemiology' in cancer, is not well understood and presents controversial aspects. Therefore, this review aims to explore the available studies concerning the relationship between obesity and cancer incidence or survival and to highlight the hypothetical explanations and the methodological framework. In this regard, we underline the limits of BMI as a potential marker of adiposity and the relevance to assessing body composition, beyond the body size. Further studies are needed to define the impact of obesity in cancer patients, to tailor weight management after cancer diagnosis and to hopefully improve overall clinical outcome.

Keywords: Body composition; Body mass index; Cancer; Obesity; Obesity paradox; Sarcopenia.

Publication types

  • Review

MeSH terms

  • Body Composition*
  • Body Mass Index*
  • Humans
  • Neoplasms / complications*
  • Obesity / complications*